Medical Management of Older Patients with HIV/AIDS (R21) | Apply Online

Frequently Asked Questions (FAQs)

What is the Medical Management of Older Patients with HIV/AIDS (R21) opportunity?

It is an NIH discretionary grant opportunity (Funding Opportunity Number PA-09-019) intended to stimulate early-stage, exploratory research on how HIV is diagnosed and medically managed in older adults, with an emphasis on work that can improve real-world clinical care and outcomes.

Which NIH activity code/mechanism does this funding use?

This announcement uses the NIH Exploratory/Developmental Research Grant mechanism (R21), which is commonly used for pilot studies, proof-of-concept projects, and other innovative or higher-risk efforts that can establish a foundation for larger follow-on studies.

Who sponsors this FOA?

The FOA is jointly sponsored by the National Institute on Aging (NIA), the National Institute of Allergy and Infectious Diseases (NIAID), and the Center for Mental Health Research on AIDS within the National Institute of Mental Health (NIMH).

What kinds of research does this FOA emphasize?

The central emphasis is on clinical and translational questions. Projects should be positioned to improve medical care, clinical decision-making, or clinical outcomes for older people living with HIV, including medical consequences and complications that emerge as individuals age with the virus.

Is the focus basic science or clinical/translational work?

Based on the description provided, the FOA centers on clinical and translational research. The intent is to generate findings that can inform diagnosis and management strategies in real-world clinical settings for older adults with HIV.

What does "older patients with HIV/AIDS" mean in the context of this opportunity?

The opportunity targets research on aging individuals living with HIV, specifically addressing how diagnosis and medical management change or become more complex as patients age and experience long-term consequences of infection and treatment.

What is meant by "medical management" in this FOA?

Medical management here refers to how clinicians diagnose and treat HIV in older adults, including strategies to handle complications, long-term consequences of HIV and treatment, and practical challenges that arise in providing care as patients age.

What types of topics or problems are in scope?

The scope is broadly described but points toward research that improves diagnosis and management strategies for older patients with HIV. Examples of in-scope areas (as implied by the description) include translating clinical observations into better care pathways, evaluating approaches to managing coexisting conditions common in older adults, and addressing practical clinical challenges in treating aging individuals with HIV.

Does the FOA include mental health-related issues?

Yes, the description signals interest in medically relevant intersections where mental health factors affect HIV outcomes in older adults, particularly when those questions are tied to clinical management. This is reinforced by NIMH participation through its Center for Mental Health Research on AIDS.

How does this R21 FOA relate to the companion R03 and R01 announcements?

The scientific scope is shared with two companion announcements: an R03 small grant mechanism (PA-09-018) and an R01 research project grant mechanism (PA-09-017). Applicants can pursue similar themes but select a mechanism aligned with the maturity, scale, and cost of the proposed work, with the R21 positioned between the limited-scope R03 and the more comprehensive R01.

What is the typical role of an R21 in NIH funding?

As described, the R21 is typically intended for exploratory, early-stage research such as pilot studies and proof-of-concept work. It supports projects that may be innovative or higher-risk, but that can produce a clear basis for later, larger studies.

How much funding is available under this opportunity?

Funding specifics are described as flexible: award size and duration vary depending on the proposed project. The listing provides an award ceiling of $200,000, reflecting the typical scale expected for this R21 opportunity.

How many awards will NIH make?

The number of awards and total dollars committed depend on the number of applications received, their scientific quality, the proposed timelines, and the proposed budgets.

Is cost sharing or matching required?

No. The opportunity explicitly states that no cost sharing or matching is required.

Which organizations are eligible to apply?

Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), state and local governments (including city, county, special district, and independent school districts), U.S. territories or possessions, tribal governments (federally recognized and other tribal entities), tribal colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), faith-based or community-based organizations, regional organizations, public housing authorities/Indian housing authorities, and certain for-profit organizations (other than small businesses). Small businesses are also listed as eligible applicants.

Are for-profit organizations eligible?

Yes. The eligibility list includes certain for-profit organizations (other than small businesses) and also separately lists small businesses as eligible applicants.

Can government entities apply?

Yes. The eligibility list includes state and local governments and also includes U.S. territories or possessions, as well as tribal governments.

Are tribal organizations and tribal colleges eligible?

Yes. Eligible applicants include tribal governments (both federally recognized and other tribal entities) as well as tribal colleges and universities.

Are community-based or faith-based organizations eligible?

Yes. Faith-based or community-based organizations are specifically included among eligible applicants.

Do minority-serving institutions qualify?

Yes. The eligibility list includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, and Alaska Native and Native Hawaiian Serving Institutions.

What CFDA program areas are associated with this opportunity?

This NIH opportunity is associated with CFDA program areas covering mental health research (93.242), microbiology and infectious diseases research (93.856), and aging research (93.866).

When was this opportunity posted, and what are the key dates mentioned?

The record indicates it was posted on October 29, 2008. It lists an original closing date of January 7, 2012, and a current closing date of May 7, 2012. It also shows an archive date of June 7, 2012.

Is this FOA still open for applications?

No. The record indicates the opportunity moved to archive status after its final closing window, with an archive date of June 7, 2012.

Where could applicants access the full announcement details?

The full announcement was made available through the NIH Grants Guide webpage referenced by the source information for this opportunity.

Who provides technical help for accessing or linking to the announcement?

Technical help for accessing or linking to the announcement is routed through the NIH Office of Extramural Research (OER) webmaster contact, as indicated in the provided information.

What is the main practical goal of projects funded under this FOA?

The stated goal is to support clinical and translational research that can improve how HIV is diagnosed and medically managed in older adults, leading to better clinical decision-making and outcomes and addressing complications that can arise with aging and long-term infection and treatment.